Novartis, a leading global medicines company, today (March 3) announced a strategic partnership with UAE-based Pharmax Pharmaceuticals, which manufactures and markets affordable, branded generic medication.
The agreement will cover the commercialisation of oral antidiabetic and oral antihypertensive medicines to enhance care and treatment outcomes for these conditions.